Syndrome of inappropriate antidiuretic hormone primary prevention: Difference between revisions
| Line 3: | Line 3: | ||
{{CMG}}{{Vbe}} | {{CMG}}{{Vbe}} | ||
==Overview== | ==Overview== | ||
SIADH to some extent can be avoided by regular review and monitoring of drugs by the health care provider. | There is no established method for prevention of SIADH. SIADH to some extent can be avoided by regular review and monitoring of drugs by the health care provider. | ||
==Prevention== | ==Prevention== | ||
Revision as of 20:00, 8 August 2017
|
Syndrome of inappropriate antidiuretic hormone Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Syndrome of inappropriate antidiuretic hormone primary prevention On the Web |
|
American Roentgen Ray Society Images of Syndrome of inappropriate antidiuretic hormone primary prevention |
|
FDA on Syndrome of inappropriate antidiuretic hormone primary prevention |
|
CDC on Syndrome of inappropriate antidiuretic hormone primary prevention |
|
Syndrome of inappropriate antidiuretic hormone primary prevention in the news |
|
Blogs on Syndrome of inappropriate antidiuretic hormone primary prevention |
|
Directions to Hospitals Treating Syndrome of inappropriate antidiuretic hormone |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Vindhya BellamKonda, M.B.B.S [2]
Overview
There is no established method for prevention of SIADH. SIADH to some extent can be avoided by regular review and monitoring of drugs by the health care provider.
Prevention
- Tell your doctor and monitor blood and urine levels of electrolytes and osmolality when taking drugs such as nonsteroidal anti-inflammatory drugs, nicotine, diuretics, chlorpropamide, carbamazepine, tricyclic antidepressants, selective serotonin reuptake inhibitors, vincristine, thioridazine, cyclophosphamide, clofibrate, bromocriptine, haloperidol, thiothixene, exogenous oxytocin.